Clinical Trials Directory

Trials / Unknown

UnknownNCT05412108

Prospective Evaluation of Complications of MidLine Catheters in the ICU

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Centre Hospitalier le Mans · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Midline catheters (MCs) are peripheral catheters inserted into a vein in the arm above the elbow crease, with the tip in the axillary vein. As such, they do not enter the central venous circulation and are therefore not considered central venous catheters. The main complications associated with CM are accidental removal, leakage, subcutaneous diffusion and occlusion. Severe complications include deep vein thrombosis (DVT) and catheter-related bacteremia (CRB). There is very little data on the use of CMs in intensive care units (ICU). Resuscitation patients are more likely to develop severe catheter-related complications such as deep vein thrombosis and catheter-related infections. While the use of CMs in patients appears to be associated with a low risk of complications, this may not be the case in resuscitation patients. Investigator therefore proposes to conduct a prospective observational study to determine the frequency and type of complications associated with CMs when they are implanted and used in ICU. In addition, investigator will attempt to determine whether risk factors predictive of complications can be identified. In addition, this study will evaluate whether the use of CMs can reduce the duration of central venous catheter maintenance in the ICU and the risk of central venous catheter-related infections.

Conditions

Timeline

Start date
2022-01-20
Primary completion
2025-01-20
Completion
2025-03-01
First posted
2022-06-09
Last updated
2022-06-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05412108. Inclusion in this directory is not an endorsement.